PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25891195-7	2015	EXPERT OPINION: The most advanced CA IX inhibitors candidates, which demonstrate antimetastatic activity in breast cancer, are the sulfonamides, with one compound (SLC-0111) currently in Phase I clinical development.	Sulfonamides	131-143	carbonic anhydrase 9	Homo sapiens	34-39